We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCW
1101
DELISTED
Mister Car Wash
MCW
$54.6K ﹤0.01%
10,238
-14,110
-58% -$83.2K
NEWP
1102
New Pacific Metals
NEWP
$1.16B
$54.3K ﹤0.01%
20,020
-33,928
-63% -$63K
STXS icon
1103
Stereotaxis
STXS
$143M
$54.1K ﹤0.01%
17,394
-14,549
-46% -$37.7K
GSIT icon
1104
GSI Technology
GSIT
$255M
$52.3K ﹤0.01%
+14,200
New +$53.5K
FUFU icon
1105
BitFuFu
FUFU
$215M
$47.8K ﹤0.01%
+12,756
New +$47.9K
NFGC
1106
New Found Gold
NFGC
$653M
$47.3K ﹤0.01%
19,938
-12,297
-38% -$21.6K
ANRO icon
1107
Alto Neuroscience
ANRO
$1.1B
$45.8K ﹤0.01%
11,401
– –
DVLT
1108
Datavault AI
DVLT
$256M
$43.4K ﹤0.01%
+40,520
New +$21.5K
STLN
1109
Starling Oncology, Inc. Common Stock
STLN
$616M
$41.5K ﹤0.01%
+11,880
New +$40.7K
ARTV
1110
Artiva Biotherapeutics
ARTV
$549M
$41K ﹤0.01%
+14,302
New +$38.3K
FTEK icon
1111
Fuel Tech
FTEK
$43.1M
$39.7K ﹤0.01%
+13,233
New +$38.4K
LRMR icon
1112
Larimar Therapeutics
LRMR
$417M
$35.1K ﹤0.01%
10,867
– –
HPP
1113
Hudson Pacific Properties
HPP
$740M
$34.5K ﹤0.01%
+1,786
New +$33.7K
SND icon
1114
Smart Sand
SND
$197M
$25.9K ﹤0.01%
12,107
-3,293
-21% -$6.51K
EGHT icon
1115
8x8 Inc
EGHT
$324M
$25.8K ﹤0.01%
+12,165
New +$24.5K
KLTR icon
1116
Kaltura
KLTR
$250M
$15.7K ﹤0.01%
10,900
– –
BACCR
1117
Blue Acquisition Corp Right
BACCR
$7.26K ﹤0.01%
+45,000
New +$6.67K
KPLTW
1118
DELISTED
Katapult Holdings Warrant
KPLTW
$195 ﹤0.01%
28,680
– –
ABCL icon
1119
AbCellera Biologics
ABCL
$2.85B
– –
-64,813
Closed -$222K
ACAD icon
1120
Acadia Pharmaceuticals
ACAD
$5.06B
– –
-27,511
Closed -$593K
ACHR icon
1121
Archer Aviation
ACHR
$4.78B
– –
-21,485
Closed -$233K
ACM icon
1122
Aecom
ACM
$9.42B
– –
-1,875
Closed -$212K
ADC icon
1123
Agree Realty
ADC
$9.22B
– –
-7,570
Closed -$553K
ADEA icon
1124
Adeia
ADEA
$3.07B
– –
-12,769
Closed -$181K
ADSK icon
1125
Autodesk
ADSK
$54.1B
– –
-839
Closed -$260K
43 44
45
46 47

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.